Mylan Launches One of the First Generic Versions of Trilipix Capsules

PITTSBURGH July 15 2013 PRNewswire &160;Mylan Inc. Nasdaq MYL today announced that its U.S.based subsidiary Mylan Pharmaceuticals Inc. has launched Fenofibric Acid Delayedrelease Capsules 45 mg and 135 mg. Fenofibric Acid Delayedrelease Capsules 45 mg...